Clinical trial Recruiting at 1 site Interventional

Detecting fast brain signals to improve epilepsy treatment

Official title: Using Micro-filaments to Detect "fast Ripples" and Improve the Identification of the Epileptogenic Zone

Run by McGill University · NCT05254730 · Data updated 2026-11-12

This study is testing new tiny electrodes to see if they can help find the source of seizures in people with hard-to-treat epilepsy, making it easier to plan better treatments.

Quick facts

Study typeInterventional
SexAll
Enrollment45 (estimated)
SponsorMcGill University
Academic / other
Locations1 site (Montreal, Quebec)
StatusRecruiting
StartedSeptember 1, 2023
Main results expectedDecember 30, 2026
Study endsDecember 30, 2028
Registry record updatedNovember 20, 2024
Trial IDNCT05254730 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with refractory epilepsy who are eligible for stereoelectroencephalography (sEEG) procedures.

Probably not a fit

Patients with severe psychiatric disorders, ongoing infections, or contraindications for MRI or intracerebral investigation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the identification of the epileptogenic zone in patients with refractory epilepsy by using novel intracranial electrodes equipped with micro-tetrodes to record fast ripples. The approach focuses on improving localization and reducing monitoring duration, particularly for patients who do not have enough seizures during the implantation period. Additionally, the study seeks to provide better surgical treatment options for patients whose previous assessments with macro-electrodes were inconclusive. The data collected will also contribute to a deeper understanding of the neuronal circuits involved in epilepsy.

Why it matters

Potential benefit: If successful, this study could lead to more accurate identification of the epileptogenic zone, resulting in improved surgical outcomes for epilepsy patients.

How similar studies have gone: While this approach is innovative, similar studies using advanced electrode technology have shown promise in improving epilepsy treatment outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* inclusion criteria is determined based on the clinical diagnosis of the refractory epilepsy and the admissibility of the patient for the stereoelectroencephalography (sEEG) procedure

Exclusion Criteria:

* severe psychiatric disorders,
* severe agitation during their crisis
* contraindication for performing an MRI: claustrophobia, a cardiac or neural stimulator, ferromagnetic surgical clips, cochlear implants, intraocular metallic foreign body or in the nervous system,
* contraindication to intracerebral investigation (macro-electrodes): ongoing infection, severe associated pathology (cardiac, pulmonary, renal, hepatic), pregnant or nursing women,
* anti thrombotic ongoing treatment.

Where it's running

  • McGill University
    Montreal, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.